tryptophan has been researched along with Non-alcoholic Fatty Liver Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 10 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Q; Liu, L; Ma, X; Meng, L; Shao, K; Yan, C; Zhang, C; Zhang, F; Zhang, X; Zhao, X | 1 |
| Abraham, SJK; Dedeepiya, VD; Ikewaki, N; Iwasaki, M; Levy, GA; Preethy, S; Raghavan, K; Ranganathan, N; Senthilkumar, R; Srinivasan, S; Yamamoto, N | 1 |
| de Mello, VD; Lindström, J; Männistö, V; Pihlajamäki, J; Sehgal, R; Tuomilehto, J; Uusitupa, M | 1 |
| Chen, X; Jiang, Y; Lv, Y; Ni, Z; Peng, L; Su, H; Tao, H; Yang, Z | 1 |
| Aggarwal, S; Bedi, O; Maiwall, R; Maras, JS; Pamecha, V; Ramakrishna, G; Rastogi, A; Trehanpati, N; Yadav, V | 1 |
| Chenaux-Repond, N; Dorochow, E; Geisslinger, G; Gurke, R; Hahnefeld, L; Klein, S; Kolbinger, A; Kraus, N; Ortiz, C; Pierre, S; Scholich, K; Trebicka, J; Welsch, C | 1 |
| Cao, Y; Chen, Y; Cui, H; Li, H; Li, W; Liao, J; Lv, S; Wang, Y; Wen, W; Yu, B; Zhao, J | 1 |
| Cui, A; Fan, JG; Gao, J; Han, Y; Hu, Z; Li, Y; Liu, XL; Liu, Y; Liu, Z; Ma, F; Pan, Q; Xin, FZ; Xue, Y; Zhao, ZH; Zhou, D | 1 |
| Chan, CB; El-Nezami, H; Kolehmainen, M; Kundi, ZM; Lee, JC; Leung, KS; Nordlund, E; Pihlajamäki, J; So, SSY | 1 |
| Li, X; Lu, L; Ma, X; Tang, S; Wang, X; Zhang, K; Zheng, H | 1 |
| Bhutia, YD; Ganapathy, V; Ramachandran, S; Sikder, MOF; Sivaprakasam, S; Wachtel, MW | 1 |
| Fan, JG; Lai, JK; Qiao, L; Zhao, ZH | 1 |
| Fan, JG; Zhou, D | 1 |
| Brzozowski, T; Celinski, K; Cichoz-Lach, H; Konturek, PC; Konturek, SJ; Korolczuk, A; Slomka, M | 1 |
| Bárdos, G; Bischoff, SC; Böhle, M; Hubert, A; Ritze, Y | 1 |
4 review(s) available for tryptophan and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Bacteria; Diabetes Mellitus, Type 2; Humans; Liver; Non-alcoholic Fatty Liver Disease; Tryptophan | 2022 |
Gut Barrier Proteins Mediate Liver Regulation by the Effects of Serotonin on the Non-Alcoholic Fatty Liver Disease.
Topics: Animals; Endotoxins; Gastrointestinal Motility; Gene Expression Regulation; Humans; Intestinal Mucosa; Liver; Mice; Non-alcoholic Fatty Liver Disease; Occludin; Permeability; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Tryptophan; Tryptophan Hydroxylase | 2020 |
Role of gut microbial metabolites in nonalcoholic fatty liver disease.
Topics: Bacteria; Bile Acids and Salts; Energy Metabolism; Gastrointestinal Microbiome; Humans; Lipopolysaccharides; Non-alcoholic Fatty Liver Disease; Receptors, G-Protein-Coupled; Tryptophan | 2019 |
Microbial metabolites in non-alcoholic fatty liver disease.
Topics: Bile Acids and Salts; Disease Progression; Ethanol; Fatty Acids, Volatile; Fermentation; Gastrointestinal Microbiome; Humans; Liver; Methylamines; Non-alcoholic Fatty Liver Disease; Prebiotics; Reproducibility of Results; Risk Factors; Signal Transduction; Tryptophan | 2019 |
1 trial(s) available for tryptophan and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up.
Topics: Adult; Cholesterol, LDL; Cytokines; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Lipid Metabolism; Liver; Male; Melatonin; Middle Aged; Non-alcoholic Fatty Liver Disease; Phosphatidylcholines; Triglycerides; Tryptophan; Young Adult | 2014 |
10 other study(ies) available for tryptophan and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Indole-3-acetic acid improves the hepatic mitochondrial respiration defects by PGC1a up-regulation.
Topics: Glucose; Humans; Indoleacetic Acids; Liver; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Respiration; RNA, Small Interfering; Tryptophan; Up-Regulation | 2022 |
Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Firmicutes; Fructose; Gastrointestinal Microbiome; Glucans; Humans; Isoleucine; Leucine; Metabolome; Mice; Non-alcoholic Fatty Liver Disease; Ornithine; RNA, Ribosomal, 16S; Spermidine; Succinic Acid; Telmisartan; Tryptophan; Water | 2022 |
Inulin intervention attenuates hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier function.
Topics: Animals; Fatty Acids, Volatile; Gastrointestinal Microbiome; Inulin; Non-alcoholic Fatty Liver Disease; Rats; Tryptophan | 2023 |
Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum.
Topics: Amino Acids; Hepatocytes; Humans; Kynurenine; Liver; Liver Cirrhosis; NAD; Non-alcoholic Fatty Liver Disease; Palmitates; Palmitic Acid; Tryptophan | 2023 |
Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice.
Topics: Animals; Disease Models, Animal; Fatty Acids; Kynurenine; Lipidomics; Liver; Metabolomics; Mice; Non-alcoholic Fatty Liver Disease; Tryptophan | 2023 |
Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver.
Topics: Animals; Feces; Gastrointestinal Microbiome; Histidine; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Polygala; RNA, Ribosomal, 16S; Tryptophan | 2023 |
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Dysbiosis; Endotoxins; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Indoles; Interleukin-1beta; Interleukin-6; Liver; Macrophages; NF-kappa B; Non-alcoholic Fatty Liver Disease; Occludin; Propionates; Rats; Tryptophan; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein | 2019 |
Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism.
Topics: Animals; Avena; Bile Acids and Salts; Body Composition; Diet, Western; Dietary Fiber; Fatty Acids, Volatile; Gastrointestinal Microbiome; Glucose; Hepatitis; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Secale; Tryptophan; Weight Gain | 2021 |
α-Methyl-l-tryptophan as a weight-loss agent in multiple models of obesity in mice.
Topics: Amino Acid Transport Systems; Animals; Anti-Obesity Agents; Diet, High-Fat; Disease Models, Animal; Female; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Tryptophan | 2021 |
Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice.
Topics: Animals; Biological Transport; Dietary Supplements; Disease Models, Animal; Duodenum; Enzyme Induction; Fatty Liver; Gastrointestinal Motility; Intestinal Mucosa; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Occludin; Organ Size; Serotonin; Serotonin Plasma Membrane Transport Proteins; Specific Pathogen-Free Organisms; Tight Junctions; Triglycerides; Tryptophan; Tryptophan Hydroxylase | 2014 |